公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2020 | Optimal clinical management and the molecular biology of angiosarcomas | WEI-WU CHEN ; Burns J.; Jones R.L.; Huang P.H. | Cancers | 15 | 16 | |
2021 | Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature | Frezza A.M.; Ravi V.; Lo Vullo S.; Vincenzi B.; Tolomeo F.; WEI-WU CHEN ; Teterycz P.; Baldi G.G.; Italiano A.; Penel N.; Brunello A.; Duffaud F.; Hindi N.; Iwata S.; Smrke A.; Fedenko A.; Gelderblom H.; Van Der Graaf W.; Vozy A.; Connolly E.; Grassi M.; Benjamin R.S.; Broto J.-M.; Grignani G.; Jones R.L.; Kawai A.; Tysarowski A.; Mariani L.; Casali P.G.; Stacchiotti S. | Cancer Medicine | 21 | 18 | |
2020 | Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study | Gounder M.; Sch?ffski P.; Jones R.L.; Agulnik M.; Cote G.M.; Villalobos V.M.; Attia S.; Chugh R.; WEI-WU CHEN ; Jahan T.; Loggers E.T.; Gupta A.; Italiano A.; Demetri G.D.; Ratan R.; Davis L.E.; Mir O.; Dileo P.; Van Tine B.A.; Pressey J.G.; Lingaraj T.; Rajarethinam A.; Sierra L.; Agarwal S.; Stacchiotti S. | The Lancet Oncology | 196 | 149 |